SCHEMBL21098149

SCHEMBL21098149

CC(C)NC(=O)NSc1ccc(C(C)(C)C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 2/20 0.41
NR1H4 Q96RI1 4/20 0.40
HDAC1 Q13547 1/20 0.40
MEN1 O00255 2/20 0.39
NPC1 O15118 2/20 0.39
KMT2A Q03164 2/20 0.39
LMNA P02545 1/20 0.39
EPHX2 P34913 4/20 0.38
HTT P42858 3/20 0.38
MAPT P10636 2/20 0.38
RAB9A P51151 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
TRPV1 Q8NER1 2/20 0.38
XBP1 P17861 1/20 0.38
MAPK1 P28482 1/20 0.38
ACE P12821 1/20 0.38
ACACB O00763 2/20 0.37
ALPL P05186 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24691341 0.81 HPGD (0.51) SMN1; SMN2ALDH1A1MEN1NPC1KMT2A
SCHEMBL19629770 0.81 SMN1; SMN2 (0.45) SMN1; SMN2ALDH1A1NR1H4HDAC1MEN1
SCHEMBL20048953 0.80 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1NR1H4HDAC1NPC1
SCHEMBL24325340 0.76 ALDH1A1 (0.54) SMN1; SMN2ALDH1A1NR1H4HDAC1MEN1
SCHEMBL30984365 0.76 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1NR1H4HDAC1MEN1
SCHEMBL19345855 0.75 KMT2A (0.44) SMN1; SMN2ALDH1A1MEN1NPC1KMT2A
SCHEMBL17149422 0.75 SMN1; SMN2 (0.62) SMN1; SMN2NR1H4MEN1NPC1KMT2A
SCHEMBL12377330 0.72 NR1H4 (0.63) ALDH1A1NR1H4HDAC1MEN1NPC1
SCHEMBL19627369 0.70 NLRP3 (0.53) ALDH1A1MEN1KMT2AEPHX2MAPT
SCHEMBL19632078 0.69 LMNA (0.44) SMN1; SMN2ALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019118571-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. (US) 2019-06-20 WO disclosed